 Proteoglycans
"Proteoglycans" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glycoproteins which have a very high polysaccharide content.
| Descriptor ID |
D011509
|
| MeSH Number(s) |
D09.698.735 D12.776.395.650
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Proteoglycans".
Below are MeSH descriptors whose meaning is more specific than "Proteoglycans".
This graph shows the total number of publications written about "Proteoglycans" by people in UAMS Profiles by year, and whether "Proteoglycans" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2023 | 1 | 1 | 2 | | 2022 | 0 | 1 | 1 | | 2021 | 1 | 2 | 3 | | 2019 | 1 | 0 | 1 | | 2018 | 0 | 1 | 1 | | 2017 | 1 | 0 | 1 | | 2014 | 1 | 1 | 2 | | 2011 | 0 | 1 | 1 | | 2010 | 0 | 1 | 1 | | 2008 | 3 | 2 | 5 | | 2007 | 1 | 2 | 3 | | 2006 | 0 | 2 | 2 | | 2005 | 2 | 1 | 3 | | 2004 | 1 | 0 | 1 | | 2003 | 4 | 2 | 6 | | 2002 | 3 | 2 | 5 | | 2001 | 2 | 1 | 3 | | 2000 | 1 | 0 | 1 | | 1999 | 2 | 1 | 3 | | 1998 | 1 | 0 | 1 | | 1997 | 1 | 0 | 1 | | 1994 | 1 | 0 | 1 | | 1990 | 2 | 0 | 2 | | 1989 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Proteoglycans" by people in Profiles over the past ten years.
-
Sallee CJ, Hippensteel JA, Miller KR, Oshima K, Pham AT, Richter RP, Belperio J, Sierra YL, Schwingshackl A, Mourani PM, Schmidt EP, Sapru A, Maddux AB. Endothelial Glycocalyx Degradation Patterns in Sepsis-Associated Pediatric Acute Respiratory Distress Syndrome: A Single Center Retrospective Observational Study. J Intensive Care Med. 2024 Mar; 39(3):277-287.
-
Nounamo B, Jousheghany F, Siegel ER, Post SR, Kelly T, Ferrone S, Kieber-Emmons T, Monzavi-Karbassi B. VT68.2: An Antibody to Chondroitin Sulfate Proteoglycan 4 (CSPG4) Displays Reactivity against a Tumor-Associated Carbohydrate Antigen. Int J Mol Sci. 2023 Jan 28; 24(3).
-
Babaahmadi-Rezaei H, Rezaei M, Ghaderi-Zefrehi H, Azizi M, Beheshti-Nasab H, Mehta JL. Reducing Proteoglycan Synthesis and NOX Activity by ROCK Inhibitors: Therapeutic Targets in Atherosclerosis. Endocr Metab Immune Disord Drug Targets. 2022; 22(12):1191-1200.
-
Caza TN, Hassen SI, Kenan DJ, Storey A, Arthur JM, Herzog C, Edmondson RD, Bourne TD, Beck LH, Larsen CP. Transforming Growth Factor Beta Receptor 3 (TGFBR3)-Associated Membranous Nephropathy. Kidney360. 2021 08 26; 2(8):1275-1286.
-
Adusumalli R, ?sheim HC, Lupashin V, Blackburn JB, Prydz K. Proteoglycan synthesis in conserved oligomeric Golgi subunit deficient HEK293T cells is affected differently, depending on the lacking subunit. Traffic. 2021 07; 22(7):230-239.
-
Chanzu H, Lykins J, Wigna-Kumar S, Joshi S, Pokrovskaya I, Storrie B, Pejler G, Wood JP, Whiteheart SW. Platelet a-granule cargo packaging and release are affected by the luminal proteoglycan, serglycin. J Thromb Haemost. 2021 04; 19(4):1082-1095.
-
Patil P, Dong Q, Wang D, Chang J, Wiley C, Demaria M, Lee J, Kang J, Niedernhofer LJ, Robbins PD, Sowa G, Campisi J, Zhou D, Vo N. Systemic clearance of p16INK4a -positive senescent cells mitigates age-associated intervertebral disc degeneration. Aging Cell. 2019 06; 18(3):e12927.
-
Jamshidi-Parsian A, Griffin RJ, Kore RA, Todorova VK, Makhoul I. Tumor-endothelial cell interaction in an experimental model of human hepatocellular carcinoma. Exp Cell Res. 2018 11 01; 372(1):16-24.
-
Lam NT, Lam H, Sturdivant NM, Balachandran K. Fabrication of a matrigel-collagen semi-interpenetrating scaffold for use in dynamic valve interstitial cell culture. Biomed Mater. 2017 Jul 24; 12(4):045013.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|